Switch to:

Arena Pharmaceuticals Debt-to-Asset

: 0.04 As of Jun. 2019
View and export this data going back to 2000. Start your Free Trial

Arena Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2019 was $3.5 Mil. Arena Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2019 was $47.6 Mil. Arena Pharmaceuticals's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2019 was $1,284.5 Mil. Arena Pharmaceuticals's debt to asset for the quarter that ended in Jun. 2019 was 0.04.


Arena Pharmaceuticals Debt-to-Asset Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Arena Pharmaceuticals Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Debt-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.27 0.39 0.18 0.08

Arena Pharmaceuticals Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Debt-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.10 0.08 0.04 0.04

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Arena Pharmaceuticals Debt-to-Asset Distribution

* The bar in red indicates where Arena Pharmaceuticals's Debt-to-Asset falls into.



Arena Pharmaceuticals Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Arena Pharmaceuticals's Debt-to-Asset Ratio for the fiscal year that ended in Dec. 2018 is calculated as

s
Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(3.283 + 49.426) / 686.903
=0.08

Arena Pharmaceuticals's Debt-to-Asset Ratio for the quarter that ended in Jun. 2019 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(3.541 + 47.598) / 1284.535
=0.04

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arena Pharmaceuticals  (NAS:ARNA) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Arena Pharmaceuticals Debt-to-Asset Related Terms


Arena Pharmaceuticals Debt-to-Asset Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}